Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies – The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies – The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 14, Issue -, Pages 3115-3124
Publisher
Informa UK Limited
Online
2021-08-11
DOI
10.2147/idr.s322812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
- (2020) Piaopiao Zhang et al. Infection and Drug Resistance
- Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia
- (2020) Yuanqi Zhao et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China
- (2020) Ting Liang et al. Microbial Drug Resistance
- Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients
- (2019) Jianling Liu et al. Journal of Infection in Developing Countries
- Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies
- (2019) Duygu Mert et al. Journal of Infection in Developing Countries
- Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infections
- (2019) Yishu Tang et al. INFECTION
- Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
- (2018) Sebastian Scheich et al. ANNALS OF HEMATOLOGY
- Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections
- (2018) Yishu Tang et al. INFECTION
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Update of Sepsis in the Intensive Care Unit
- (2017) Kelly Roveran Genga et al. Journal of Innate Immunity
- Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa , and vancomycin-resistant Enterococcus : Three major threats to hematopoietic stem cell transplant recipients
- (2017) Michael J. Satlin et al. Transplant Infectious Disease
- Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia
- (2016) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies
- (2016) Michael J. Satlin et al. JOURNAL OF INFECTION
- Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
- (2015) E.M. Trecarichi et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China
- (2015) Weihua Zhai et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit
- (2015) P. Cornejo-Juárez et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours
- (2014) Mar Marin et al. JOURNAL OF INFECTION
- Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria
- (2014) Markus Ruhnke et al. LANCET ONCOLOGY
- European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
- (2013) D. Averbuch et al. HAEMATOLOGICA
- Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
- (2013) Young Eun Ha et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome
- (2012) Si-Hyun Kim et al. ANNALS OF HEMATOLOGY
- Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
- (2012) C. Gudiol et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
- (2011) Cheol-In Kang et al. ANNALS OF HEMATOLOGY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies
- (2010) E. M. Trecarichi et al. HAEMATOLOGICA
- Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia
- (2009) C.-Y. CHEN et al. EPIDEMIOLOGY AND INFECTION
- Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
- (2009) C. Gudiol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now